| scholarly article | Q13442814 |
| P50 | author | Christophe Benoist | Q87765385 |
| P2093 | author name string | Diane Mathis | |
| Hitoshi Kikutani | |||
| Kenji Yoshida | |||
| Michael B A Oldstone | |||
| Luc Teyton | |||
| Kathryn Haskins | |||
| Grigoriy Losyev | |||
| Thomas Stratmann | |||
| Natalia Martin-Orozco | |||
| Laurent Poirot | |||
| Cathleen M Dobbs | |||
| Dorian McGavern | |||
| Valérie Mallet-Designe | |||
| P2860 | cites work | Estimating the precursor frequency of naive antigen-specific CD8 T cells | Q24674109 |
| A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes | Q27622298 | ||
| Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice | Q27625365 | ||
| Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes | Q27632133 | ||
| Phenotypic analysis of antigen-specific T lymphocytes | Q28290058 | ||
| T-cell antigen receptor genes and T-cell recognition | Q29619721 | ||
| Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice | Q30644510 | ||
| Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones | Q30872028 | ||
| Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR. | Q30872493 | ||
| The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder | Q30919440 | ||
| Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction | Q32123429 | ||
| Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization | Q33731073 | ||
| Delineation of antigen contact residues on an MHC class II molecule | Q33923511 | ||
| Pancreatic islet-specific T-cell clones from nonobese diabetic mice | Q34313103 | ||
| Following a diabetogenic T cell from genesis through pathogenesis | Q70488192 | ||
| The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders | Q70843994 | ||
| Insulin-dependent diabetes mellitus | Q71046915 | ||
| High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice | Q71641038 | ||
| Organ-specific disease provoked by systemic autoimmunity | Q71838378 | ||
| Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes | Q73014358 | ||
| Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme | Q73216181 | ||
| Genetic control of diabetes progression | Q74045636 | ||
| A defect in central tolerance in NOD mice | Q74825850 | ||
| Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes | Q77192908 | ||
| Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors | Q77338435 | ||
| A new look at MHC and autoimmune disease | Q77771995 | ||
| Human DQ8 can substitute for murine I-Ag7 in the selection of diabetogenic T cells restricted to I-Ag7 | Q77801073 | ||
| Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models | Q34376868 | ||
| The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. | Q34452348 | ||
| The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique | Q34614636 | ||
| The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire | Q35602289 | ||
| T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice | Q36230116 | ||
| Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. | Q36364198 | ||
| Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules | Q36366719 | ||
| Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes | Q36367942 | ||
| Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice | Q36380895 | ||
| Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes | Q36400199 | ||
| Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice | Q36678330 | ||
| Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. | Q36705248 | ||
| Molecular anatomy of antigen-specific CD8(+) T cell engagement and synapse formation in vivo | Q36787434 | ||
| Massive expansion of antigen-specific CD8+ T cells during an acute virus infection | Q37419599 | ||
| Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors. | Q37548447 | ||
| Checkpoints in the progression of autoimmune disease: lessons from diabetes models | Q37689425 | ||
| Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues | Q38464540 | ||
| Genetic Control of Specific Immune Responses | Q39988595 | ||
| Genetic control of autoimmune diabetes in the NOD mouse | Q40444847 | ||
| Antigen-selected T-cell receptor diversity and self-nonself homology | Q40858305 | ||
| Genetic analysis of autoimmune disease | Q40980040 | ||
| The search for IDDM susceptibility genes: the next generation | Q40981935 | ||
| Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen | Q41489831 | ||
| Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity | Q41605782 | ||
| Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes | Q41689049 | ||
| The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes | Q41731978 | ||
| Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts | Q42115050 | ||
| Tolerance and immunity to the inducible self antigen C-reactive protein in transgenic mice | Q42514204 | ||
| Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity | Q43433033 | ||
| In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes | Q43860764 | ||
| The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex | Q43926964 | ||
| In situ detection of virus- and tumor-specific T-cell immunity | Q44528213 | ||
| Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone | Q44534362 | ||
| Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes | Q44851100 | ||
| Molecular basis for HLA-DQ associations with IDDM. | Q45113087 | ||
| Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry | Q45754853 | ||
| Ligand recognition by alpha beta T cell receptors | Q46222293 | ||
| T-lymphocyte clone specific for pancreatic islet antigen | Q46335815 | ||
| Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity | Q46792549 | ||
| Size estimate of the alpha beta TCR repertoire of naive mouse splenocytes | Q47238652 | ||
| Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides. | Q47564253 | ||
| Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes | Q47877315 | ||
| Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. | Q52016711 | ||
| Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. | Q52040367 | ||
| In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. | Q52441433 | ||
| NOD mice have a generalized defect in their response to transplantation tolerance induction. | Q54095945 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 902-914 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity | |
| P478 | volume | 112 |
| Q36653684 | Antidiabetogenic MHC class II promotes the differentiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells |
| Q43560921 | B6.g7 mice reconstituted with BDC2·5 non-obese diabetic (BDC2·5NOD) stem cells do not develop autoimmune diabetes |
| Q36399063 | CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion |
| Q37496758 | CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L. |
| Q37376821 | Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice. |
| Q53851134 | Conditioning the genome identifies additional diabetes resistance loci in Type I diabetes resistant NOR/Lt mice. |
| Q36387060 | Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes |
| Q37274444 | Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice. |
| Q34211374 | Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3 |
| Q37704508 | Cutting edge: type 1 diabetes occurs despite robust anergy among endogenous insulin-specific CD4 T cells in NOD mice |
| Q37598701 | Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis |
| Q37033008 | Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity? |
| Q40787726 | Expanding antigen-specific regulatory networks to treat autoimmunity |
| Q46889094 | Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis |
| Q42868832 | Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice |
| Q36975465 | Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice |
| Q36354925 | Imbalanced signal transduction in regulatory T cells expressing the transcription factor FoxP3. |
| Q36842573 | Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1). |
| Q46630002 | In situ staining using MHC class I tetramers |
| Q37714655 | In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesis |
| Q34527126 | Induction of mixed chimerism with MHC-mismatched but not matched bone marrow transplants results in thymic deletion of host-type autoreactive T-cells in NOD mice |
| Q24647312 | Innate immunity and intestinal microbiota in the development of Type 1 diabetes |
| Q35405281 | Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapies |
| Q49790362 | MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice |
| Q36403033 | Modifier loci condition autoimmunity provoked by Aire deficiency |
| Q33794336 | Mouse Models for Type 1 Diabetes |
| Q37593413 | Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis |
| Q37018598 | Novel autoantigens for diabetogenic CD4 T cells in autoimmune diabetes |
| Q36945852 | Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion |
| Q33221766 | Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse |
| Q33527496 | Peripherin-reactive antibodies in mouse, rabbit, and human blood |
| Q35062855 | Population dynamics of islet-infiltrating cells in autoimmune diabetes. |
| Q67994522 | Position β57 of I-Ag7 controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset |
| Q81075249 | Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes |
| Q36012386 | Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice. |
| Q35702538 | T-cell epitopes in type 1 diabetes |
| Q36287467 | Tetramer analysis of human autoreactive CD4-positive T cells |
| Q27660688 | The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity |
| Q37187340 | The genetics of multiple sclerosis: SNPs to pathways to pathogenesis |
| Q37968302 | The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding |
| Q36287487 | The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection |
| Q30982114 | Tracking autoimmune T cells in diabetes |
| Q55224664 | Treatment of T1D via optimized expansion of antigen-specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramers. |
| Q35651667 | Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes |
| Q36756575 | Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice |
| Q28506933 | Where CD4+CD25+ T reg cells impinge on autoimmune diabetes |
Search more.